Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC
![Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC](/img/v2021/product_image.png)
Product Description
SMB Laboratories SA
![SMB Laboratories SA](/smb-comp241496.png)
-
BE
-
2015On CPHI since
Company types
Categories
Specifications
SMB Laboratories SA
![SMB Laboratories SA](/smb-comp241496.png)
-
BE
-
2015On CPHI since
Company types
More Products from SMB Laboratories SA (2)
-
Product Buprenorphine + Naloxone 8/2mg, 2/0.5mg sublingual tablets (FDC)
Intro
Dossier:
Indication:
Formulation: -
Product Buprenorphine 2 mg, 8 mg sublingual tablets
Intro
Dossier:
Indication:
Formulation:
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance